PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:29 AM ET

Sponsor Check › Person

JT
No photo found yet (own website and image search run after this page is viewed)

Jesse Treu

Named as an officer, director or promoter on SEC Form D filings · NJ, CA, GA · Nov 5, 2009 → Sep 22, 2014

10deals (issuers)
$585Mreported sold
194investors
28Form D filings
2009–2014years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:02 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Jesse Treu is listed as an executive officer and director on 28 SEC Form D filings by 10 issuers between May 2009 and Jul 2015. Largest by amount reported sold: Domain Partners VIII, L.P. (Princeton, NJ — pooled investment fund — 2009; $371.1M reported sold to 32 investors), Afferent Pharmaceuticals, Inc. (San Mateo, CA — pharmaceuticals — 2009–2015; $55M reported sold to 17 investors), TANDEM DIABETES CARE INC (San Diego, CA — other technology — 2009–2012; $52.3M reported sold to 43 investors), Regado Biosciences Inc (Basking Ridge, NJ — biotechnology — 2010–2014; $40M reported sold to 15 investors), CoLucid Pharmaceuticals, Inc. (Durham, NC — pharmaceuticals — 2010–2015; $37.1M reported sold to 11 investors) and 5 more (all listed below).

What this means That is a lot of deals — 10 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $585M sold in total.

Listed alongside Dennis Podlesak (9 shared filings), Arthur M. Pappas (8 shared filings), David J. Mazzo (7 shared filings), P. Sherrill Neff (7 shared filings), Jeff Clark (5 shared filings) and 80 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jesse. Each name links to their own page.

The issuers belong to 2 sponsor groups: Domain (3 issuers, $538.4M reported sold, 2009–2016) and Pappas (8 issuers, $333.7M reported sold, 2009–2024).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 28 public filings for Jesse Treu and found 12 differences: 5 Form Ds were filed more than 15 days after the first sale; 4 offerings changed their target amount between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Jesse Treu has not run yet — it is joining a line of 17,349 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:02 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Jesse Treu..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

William S Valle and Charla D Treu closed
United States Bankruptcy Court, C.D. California · No. 8:03-bk-16244 · Filed Aug 20, 2003 · Closed Dec 16, 2003
Role of William S Valle and Charla D Treu: Debtor · Outcome: Case closed 2003-12-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 13 federal dockets); different first name (charla); court in the person's filing state (CA)
Michael Ward Johnson and Kathy Treu Johnson closed
United States Bankruptcy Court, W.D. Louisiana · No. 94-11306 · Filed Sep 19, 1994 · Closed Jul 29, 1996
Role of Michael Ward Johnson and Kathy Treu Johnson: Debtor · Outcome: Case closed 1996-07-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 13 federal dockets); different first name (kathy); court in LA (not a filing state)
Michael Ward Johnson and Kathy Treu Johnson closed
United States Bankruptcy Court, W.D. Louisiana · No. 92-10181 · Filed Jan 22, 1992 · Closed Aug 29, 1994
Role of Michael Ward Johnson and Kathy Treu Johnson: Debtor · Outcome: Case closed 1994-08-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 13 federal dockets); different first name (kathy); court in LA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:02 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Jesse Treu (compared 28 filings on Oct 24, 2026)

Note · Dec 17, 2009 – Feb 25, 2014

5 Form Ds were filed more than 15 days after the first sale

Form D filed 20 days after the first sale — Regado Biosciences Inc · Form D filed 30 days after the first sale — Regado Biosciences Inc · Form D filed 18 days after the first sale — Regado Biosciences Inc · Form D filed 37 days after the first sale — Regado Biosciences Inc · Form D filed 19 days after the first sale — Regado Biosciences Inc

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Feb 25, 2014 ↗Regado Biosciences Inc — PartnerFacts page ↗Form D · Jan 17, 2013 ↗Form D · May 21, 2012 ↗
Sources
Note · Nov 5, 2009 – Jul 1, 2011

4 offerings changed their target amount between filings

Offering amount changed between filings — Regado Biosciences Inc · Offering amount changed between filings — Regado Biosciences Inc · Offering amount changed between filings — CoLucid Pharmaceuticals, Inc. · Offering amount changed between filings — Afferent Pharmaceuticals, Inc.

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Jun 30, 2011 ↗Form D/A (later) · Jul 1, 2011 ↗Regado Biosciences Inc — PartnerFacts page ↗Form D (earlier) · Jan 5, 2010 ↗
Sources
Note · Jan 20, 2009 – Nov 21, 2013

11 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — RightCare Solutions, Inc. (latest filing Nov 21, 2013) · No amendment in the last 12 months on an offering that may still be open — CoLucid Pharmaceuticals, Inc. (latest filing Jul 11, 2013) · No amendment in the last 12 months on an offering that may still be open — Regado Biosciences Inc (latest filing Jan 17, 2013) · No amendment in the last 12 months on an offering that may still be open — TANDEM DIABETES CARE INC (latest filing Sep 11, 2012) · No amendment in the last 12 months on an offering that may still be open — Regado Biosciences Inc (latest filing May 21, 2012) · and 6 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Nov 21, 2013 ↗RightCare Solutions, Inc. — PartnerFacts page ↗Form D/A · Jul 11, 2013 ↗CoLucid Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · May 13, 2009 – May 29, 2009

Jesse Treu is written 2 different ways on the filings

listed as "Jesse I. Treu" on 10 filings (from May 13, 2009), and "Jesse Treu" on 18 filings (from May 29, 2009).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · May 13, 2009 ↗Form D · May 29, 2009 ↗Jesse Treu — PartnerFacts page ↗
Sources
Note · Nov 5, 2009 – Jul 14, 2015

Industry group changed between filings — Afferent Pharmaceuticals, Inc.

"Other Health Care" (Nov 5, 2009 to Dec 18, 2009); then "Pharmaceuticals" (Jul 14, 2015).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Nov 5, 2009 ↗Form D · Jul 14, 2015 ↗Afferent Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jun 18, 2010 – Sep 30, 2014

Industry group changed between filings — VERACYTE, INC.

"Biotechnology" (Jun 18, 2010); then "Other Health Care" (Sep 30, 2014).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jun 18, 2010 ↗Form D · Sep 30, 2014 ↗VERACYTE, INC. — PartnerFacts page ↗
Sources
Note · Jan 29, 2015 – Feb 11, 2019

Same name, different state: "Jesse I. Treu" (MA or GA) is a separate record

This page covers filings where the address state is NJ or CA or GA. A separate record, "Jesse I. Treu" with address state MA or GA, is listed on 6 filings — most recently by Sebacia, Inc. (Sep 13, 2019). The two records do not overlap in time: this page runs Nov 5, 2009 to Sep 22, 2014; the other runs Jan 29, 2015 to Feb 11, 2019.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Jesse I. Treu (MA,GA) — PartnerFacts page ↗Form D · Sep 13, 2019 ↗Sebacia, Inc. — PartnerFacts page ↗Jesse Treu (NJ,CA,GA) — this page ↗
Sources
Note · Dec 18, 2009 – Jul 14, 2015

Address moved from Boston, MA to San Mateo, CA — Afferent Pharmaceuticals, Inc.

The people listed on the Dec 18, 2009 filing give Boston, MA; on the Jul 14, 2015 filing they give San Mateo, CA. The address now on file (2929 Campus Drive, Suite 230, San Mateo, CA) is a registered-agent or shared-office address used by 10 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Dec 18, 2009 ↗Form D · Jul 14, 2015 ↗Afferent Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jun 18, 2010 – Sep 30, 2014

Address moved from Menlo Park, CA to South San Francisco, CA — VERACYTE, INC.

The people listed on the Jun 18, 2010 filing give Menlo Park, CA; on the Sep 30, 2014 filing they give South San Francisco, CA. The address now on file (7000 Shoreline Court, Suite 250, South San Francisco, CA) is a registered-agent or shared-office address used by 6 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Jun 18, 2010 ↗Form D · Sep 30, 2014 ↗VERACYTE, INC. — PartnerFacts page ↗
Sources
Note · May 13, 2009 – Jul 14, 2015

Jesse Treu is listed with 3 different address states: GA, CA, NJ

GA on 1 filing (May 13, 2009); CA on 6 filings (May 29, 2009 to Jul 14, 2015); NJ on 21 filings (Jun 10, 2009 to Jan 26, 2015).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · May 13, 2009 ↗Form D · May 29, 2009 ↗Form D · Jun 10, 2009 ↗
Sources
Note · Jun 18, 2010 – Sep 30, 2014

Reported revenue range changed between filings — VERACYTE, INC.

"Decline to Disclose" (Jun 18, 2010); then "$5,000,001 - $25,000,000" (Sep 30, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jun 18, 2010 ↗Form D · Sep 30, 2014 ↗VERACYTE, INC. — PartnerFacts page ↗
Sources
Note · Jan 26, 2010 – Jul 11, 2013

Reported revenue range changed between filings — CoLucid Pharmaceuticals, Inc.

"No Revenues" (Jan 26, 2010); then "$1 - $1,000,000" (Jun 28, 2011); then "No Revenues" (Jul 11, 2013).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D/A · Jan 26, 2010 ↗Form D/A · Jun 28, 2011 ↗Form D/A · Jul 11, 2013 ↗CoLucid Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 22 offerings reports sales commissions totalling $1,200,000; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jul 14, 2015 D
Afferent Pharmaceuticals, Inc.
File 021-243651
$0$0$0None listed on this filingEDGAR ↗
Jan 26, 2015 D
CoLucid Pharmaceuticals, Inc.
File 021-232838
$0$0$0
No proceeds are proposed to be used for payment to such persons other than ordinary salary expenses that may be paid out of working capital.
None listed on this filingEDGAR ↗
Sep 30, 2014 D
VERACYTE, INC.
File 021-225555
$0$0$0None listed on this filingEDGAR ↗
Sep 22, 2014 D
RightCare Solutions, Inc.
File 021-225070
$0$0$0None listed on this filingEDGAR ↗
Feb 25, 2014 D
Regado Biosciences Inc
File 021-212433
$1,200,000$0$0Cowen and Company, LLC BrokerCheck CRD 7616 ↗
BMO Capital Markets Corp. BrokerCheck CRD 16686 ↗		EDGAR ↗
Nov 21, 2013 D
RightCare Solutions, Inc.
File 021-206776
$0$0$0None listed on this filingEDGAR ↗
Jul 11, 2013 D/A
CoLucid Pharmaceuticals, Inc.
File 021-156147
$0$0$0
No proceeds are proposed to be used for payment to such persons other than ordinary salary expenses that may be paid out of working capital.
None listed on this filingEDGAR ↗
Jan 17, 2013 D
Regado Biosciences Inc
File 021-190422
$0$0$0None listed on this filingEDGAR ↗
Sep 11, 2012 D
TANDEM DIABETES CARE INC
File 021-183927
$0$0$0None listed on this filingEDGAR ↗
May 21, 2012 D
Regado Biosciences Inc
File 021-178548
$0$0$0None listed on this filingEDGAR ↗
Aug 18, 2011 D
TANDEM DIABETES CARE INC
File 021-164659
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2011 D/A
Regado Biosciences Inc
File 021-71907
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2011 D
Regado Biosciences Inc
File 021-162222
$0$0$0None listed on this filingEDGAR ↗
Oct 25, 2010 D
Altea Therapeutics Corp
File 021-149515
$0$0$0None listed on this filingEDGAR ↗
Jun 18, 2010 D
VERACYTE, INC.
File 021-143695
$0$0$0None listed on this filingEDGAR ↗
Jan 26, 2010 D/A
CoLucid Pharmaceuticals, Inc.
File 021-84673
$0$0$0
No proceeds are proposed to be used for payment to such persons other than ordinary salary expenses that may be paid out of working capital.
None listed on this filingEDGAR ↗
Jan 8, 2010 D/A
TANDEM DIABETES CARE INC
File 021-119446
$0$0$0None listed on this filingEDGAR ↗
Dec 18, 2009 D
Afferent Pharmaceuticals, Inc.
File 021-135875
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 15, 2009 D
Somaxon Pharmaceuticals, Inc.
File 021-89181
$0$0$0None listed on this filingEDGAR ↗
Jun 18, 2009 D
Domain Partners VIII, L.P.
File 021-132078
$0$0$0None listed on this filingEDGAR ↗
Jun 10, 2009 D
DP VIII Associates, L.P.
File 021-131856
$0$0$0None listed on this filingEDGAR ↗
May 13, 2009 D
Altea Therapeutics Corp
File 021-71591
$0$0$0 (est.)
Proceeds will be used for general corporate purposes which may include salaries and bonuses for the identified executive officers
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 10

Every issuer that named Jesse Treu on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

AP
Pharmaceuticals

Afferent Pharmaceuticals, Inc.

San Mateo, CA · Nov 5, 2009 → Jul 14, 2015 · 3 filings
  • Jul 14, 2015 · D · $54,999,986 sold of $54,999,986 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 18, 2009 · D · $3,000,000 sold of $23,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 5, 2009 · D · $150,000 sold of $150,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $55M from 17 investors (100% of the $55M target) as of the latest filing. Jesse is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pharmaceuticals · group: Pappas

CoLucid Pharmaceuticals, Inc.

Durham, NC · Jan 26, 2010 → Jan 26, 2015 · 5 filings
  • Jan 26, 2015 · D · $37,100,000 sold of $37,100,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 11, 2013 · D/A · $8,250,000 sold of $9,500,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 28, 2011 · D/A · $3,500,000 sold of $9,500,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 3, 2011 · D · $2,000,000 sold of $6,500,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 26, 2010 · D/A · $9,199,981 sold of $13,799,968 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $37.1M from 11 investors (100% of the $37.1M target) as of the latest filing. Jesse is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

V
Other Health Care

VERACYTE, INC.

South San Francisco, CA · Jun 18, 2010 → Sep 30, 2014 · 2 filings
  • Sep 30, 2014 · D · $12,797,283 sold of $12,797,283 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 18, 2010 · D · $9,311,668 sold of $28,435,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $12.8M from 9 investors (100% of the $12.8M target) as of the latest filing. Jesse is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

RS
Other Health Care

RightCare Solutions, Inc.

Horsham, PA · Nov 21, 2013 → Sep 22, 2014 · 2 filings
  • Sep 22, 2014 · D · $4,000,000 sold of $4,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 21, 2013 · D · $2,999,999 sold of $5,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $4M from 8 investors (100% of the $4M target) as of the latest filing. Jesse is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

RB
Biotechnology

Regado Biosciences Inc

Basking Ridge, NJ · Jan 5, 2010 → Feb 25, 2014 · 7 filings
  • Feb 25, 2014 · D · $20,000,000 sold of $20,000,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 17, 2013 · D · $22,634,958 sold of $50,780,221 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 21, 2012 · D · $6,780,540 sold of $13,561,080 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2011 · D · $11,599,999 sold of $11,599,999 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2011 · D/A · $40,000,000 sold of $40,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 30, 2011 · D/A · $26,149,167 sold of $26,149,167 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 5, 2010 · D · $14,549,167 sold of $14,549,167 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $40M from 15 investors (100% of the $20M target) as of the latest filing. Jesse is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TD
Other Technology

TANDEM DIABETES CARE INC

San Diego, CA · May 29, 2009 → Sep 11, 2012 · 4 filings
  • Sep 11, 2012 · D · $36,387,925 sold of $50,000,000 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 18, 2011 · D · $12,001,200 sold of $13,688,478 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 8, 2010 · D/A · $52,343,055 sold of $52,343,055 · 31 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 29, 2009 · D · $21,361,164 sold of $52,343,055 · 31 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $52.3M from 43 investors (100% of the $50M target) as of the latest filing. Jesse is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

AT
Biotechnology

Altea Therapeutics Corp

Atlanta, GA · May 13, 2009 → Oct 25, 2010 · 2 filings
  • Oct 25, 2010 · D · $685,000 sold of $685,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 13, 2009 · D · $3,000,000 sold of $3,000,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3M from 8 investors (100% of the $685K target) as of the latest filing. Jesse is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SP
Pharmaceuticals

Somaxon Pharmaceuticals, Inc.

Solana Beach, CA · Jul 15, 2009
  • Jul 15, 2009 · D · $5,999,990 sold of $5,999,990 · 16 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 16 investors (100% of the $6M target) as of the latest filing. Jesse is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

DP
Pooled Investment Fund · group: Domain

Domain Partners VIII, L.P.

Princeton, NJ · Jun 18, 2009
  • Jun 18, 2009 · D · $371,070,000 sold of Indefinite · 32 investors · min. $5,000,000 · role: Executive Officer EDGAR ↗

Raised $371.1M from 32 investors as of the latest filing. Jesse is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

DV
Pooled Investment Fund · group: Domain

DP VIII Associates, L.P.

Princeton, NJ · Jun 10, 2009
  • Jun 10, 2009 · D · $3,673,000 sold of Indefinite · 35 investors · min. $50,000 · role: Executive Officer EDGAR ↗

Raised $3.67M from 35 investors as of the latest filing. Jesse is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Jesse I. Treu — MA, GA, 2 issuers, Jan 29, 2015 → Feb 11, 2019 · no shared issuer

People around Jesse 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Dennis Podlesak

Executive Officer, Director · 9 shared filings (2 issuers) · also on 7 other issuers

Dennis Podlesak is on 9 issuers in total — a repeat sponsor. Their page lists every one.

AP
No photo found yet (own website and image search run after this page is viewed)
Person

Arthur M. Pappas

Director, Executive Officer · 8 shared filings (2 issuers) · also on 9 other issuers

Arthur M. Pappas is on 11 issuers in total — a repeat sponsor. Their page lists every one.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

David J. Mazzo

Executive Officer, Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

PN
No photo found yet (own website and image search run after this page is viewed)
Person

P. Sherrill Neff

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

TG
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy C. Gupton

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

NR
No photo found yet (own website and image search run after this page is viewed)
Person

Nadia Rupniak

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Richard J. Markham

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Jesse Treu. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Clark

Director · 5 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

RW
No photo found yet (own website and image search run after this page is viewed)
Person

Raphael Wishiewski

Director · 5 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John Cajigas

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

HG
No photo found yet (own website and image search run after this page is viewed)
Person

Howard E. Greene

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

Dick Allen

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

John H. Livingston

Director · 4 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Kim D. Blickenstaff

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

LR
No photo found yet (own website and image search run after this page is viewed)
Person

Liam Ratcliffe

Director · 3 shared filings (1 issuer) · also on 10 other issuers

Liam Ratcliffe is on 11 issuers in total — a repeat sponsor. Their page lists every one.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Starr

Executive Officer, Director · 3 shared filings (1 issuer) · also on 8 other issuers

Kevin Starr is on 9 issuers in total — a repeat sponsor. Their page lists every one.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Roeder

Director · 3 shared filings (1 issuer) · also on 4 other issuers

Douglas Roeder is on 5 issuers in total — a repeat sponsor. Their page lists every one.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Cahill

Director · 3 shared filings (1 issuer) · also on 13 other issuers

Edward Cahill is on 14 issuers in total — a repeat sponsor. Their page lists every one.

DN
No photo found yet (own website and image search run after this page is viewed)
Person

David Neafus

Executive Officer · 2 shared filings (1 issuer) · also on 10 other issuers

David Neafus is on 11 issuers in total — a repeat sponsor. Their page lists every one.

EH
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Heil

Executive Officer, Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Jesse Treu. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

KATHLEEN SCHOEMAKER

Executive Officer · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

BD
No photo found yet (own website and image search run after this page is viewed)
Person

Brian H. Dovey

Executive Officer · 2 shared filings (2 issuers) · also on 13 other issuers

Brian H. Dovey is on 15 issuers in total — a repeat sponsor. Their page lists every one.

NB
No photo found yet (own website and image search run after this page is viewed)
Person

Ned Brown

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

PD
No photo found yet (own website and image search run after this page is viewed)
Person

Paul DiPerna

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Ruth Devenyns

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

FT
No photo found yet (own website and image search run after this page is viewed)
Person

Frank E. Tagliaferri

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

ET
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Tomlinson

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Angela Walsh

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Damon

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jesse Treu. Their page shows their other deals.

WG
No photo found yet (own website and image search run after this page is viewed)
Person

William R. Good

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Smith

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

BB
No photo found yet (own website and image search run after this page is viewed)
Person

Brook Byers

Director · 2 shared filings (1 issuer) · also on 21 other issuers

Brook Byers is on 22 issuers in total — a repeat sponsor. Their page lists every one.

BA
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Atwood

Director · 2 shared filings (1 issuer) · also on 14 other issuers

Brian Atwood is on 15 issuers in total — a repeat sponsor. Their page lists every one.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Fred Cohen

Director · 2 shared filings (1 issuer) · also on 23 other issuers

Fred Cohen is on 24 issuers in total — a repeat sponsor. Their page lists every one.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Halak

Executive Officer · 2 shared filings (2 issuers) · also on 16 other issuers

Brian Halak is on 18 issuers in total — a repeat sponsor. Their page lists every one.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Mitchell S. Bloom

Executive Officer · 2 shared filings (1 issuer) · also on 11 other issuers

Mitchell S. Bloom is on 12 issuers in total — a repeat sponsor. Their page lists every one.

EJ
No photo found yet (own website and image search run after this page is viewed)
Person

Evan Jones

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Jesse Treu. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Perlman

Director · 2 shared filings (1 issuer) · also on 7 other issuers

Richard Perlman is on 8 issuers in total — a repeat sponsor. Their page lists every one.

JW
No photo found yet (own website and image search run after this page is viewed)
Person

James F. White

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel L. Boeglin

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jesse Treu. Their page shows their other deals.

The team behind the deals

D
Sponsor group

Domain

3 issuers · 5 filings · $538.4M reported sold · 2009–2016

One team, 3 deal companies. Jesse Treu is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Jesse Treu.

P
Sponsor group

Pappas

8 issuers · 14 filings · $333.7M reported sold · 2009–2024

One team, 8 deal companies. Jesse Treu is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Jesse Treu.

Same business address

28 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Jesse Treu by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Jesse Treu is listed on: none on file. No website or social profile named in Domain Partners VIII, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #371,550 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Princeton, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗California — find the county court ↗Los Angeles Superior Court case search ↗Georgia state courts — find the court ↗North Carolina eCourts portal ↗Pennsylvania UJS portal case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗California Secretary of State business search ↗Georgia Secretary of State business search ↗North Carolina Secretary of State business search ↗Pennsylvania Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Jesse Treu appears on a new Form D, or when a court case or SEC action is matched to them. See plans →